Adient Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Adient de 42.9% y 1.2% por año respectivamente. Se prevé que el BPA crezca en un 43.9% al año. Se espera que la rentabilidad financiera sea de 10% en 3 años.
Información clave
42.9%
Tasa de crecimiento de los beneficios
43.9%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Auto Components | 27.9% |
Tasa de crecimiento de los ingresos | 1.2% |
Rentabilidad financiera futura | 10.0% |
Cobertura de analistas | Good |
Última actualización | 14 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Adient: Aggressive Deleveraging Needed To Minimize Impairment Charges
Nov 12Returns On Capital Are Showing Encouraging Signs At Adient (NYSE:ADNT)
Oct 09Adient plc's (NYSE:ADNT) Popularity With Investors Is Clear
Sep 19We Think You Can Look Beyond Adient's (NYSE:ADNT) Lackluster Earnings
Aug 14Earnings Miss: Adient plc Missed EPS And Analysts Are Revising Their Forecasts
Aug 09These 4 Measures Indicate That Adient (NYSE:ADNT) Is Using Debt Extensively
Aug 04Adient (NYSE:ADNT) Shareholders Will Want The ROCE Trajectory To Continue
Jun 27Lacklustre Performance Is Driving Adient plc's (NYSE:ADNT) Low P/S
Jun 12Are Investors Undervaluing Adient plc (NYSE:ADNT) By 36%?
May 26Adient: Consider Financial Prospects And Buyback Yield
May 22Here's Why Adient (NYSE:ADNT) Has A Meaningful Debt Burden
Apr 07Adient (NYSE:ADNT) Shareholders Will Want The ROCE Trajectory To Continue
Mar 20Adient plc's (NYSE:ADNT) Shares Lagging The Industry But So Is The Business
Feb 12Here's Why Adient (NYSE:ADNT) Has A Meaningful Debt Burden
Jan 07Is There An Opportunity With Adient plc's (NYSE:ADNT) 36% Undervaluation?
Dec 20Adient: Product Demand, Strength In Global Automotive Sales To Bolster Future Growth
Dec 15Returns At Adient (NYSE:ADNT) Are On The Way Up
Dec 02Adient: Too Early To Turn Bullish
Sep 26Is There An Opportunity With Adient plc's (NYSE:ADNT) 44% Undervaluation?
Sep 19Adient (NYSE:ADNT) Has A Pretty Healthy Balance Sheet
Aug 29Adient (NYSE:ADNT) Is Experiencing Growth In Returns On Capital
Aug 08Investor Optimism Abounds Adient plc (NYSE:ADNT) But Growth Is Lacking
Jul 24Adient: A Lack Of Catalysts
Jul 17These 4 Measures Indicate That Adient (NYSE:ADNT) Is Using Debt Extensively
May 15Calculating The Intrinsic Value Of Adient plc (NYSE:ADNT)
Apr 27Returns On Capital At Adient (NYSE:ADNT) Paint A Concerning Picture
Apr 06Adient: NIO And Toyota Agreements Positive, But Risks Persist
Feb 17Adient Q1 2023 Earnings Preview
Feb 06Adient (NYSE:ADNT) Has A Somewhat Strained Balance Sheet
Feb 01Is There An Opportunity With Adient plc's (NYSE:ADNT) 29% Undervaluation?
Jan 10These Return Metrics Don't Make Adient (NYSE:ADNT) Look Too Strong
Dec 20Adient: Positive On Earnings Beat And Buyback Program
Nov 08Adient names Jerome Dorlack as CFO
Oct 31Is Adient (NYSE:ADNT) A Risky Investment?
Oct 18With EPS Growth And More, Adient (NYSE:ADNT) Makes An Interesting Case
Sep 08Is Adient plc (NYSE:ADNT) Trading At A 49% Discount?
Aug 18Adient Q3 2022 Earnings Preview
Aug 04Here's Why Adient (NYSE:ADNT) Is Weighed Down By Its Debt Load
May 25Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
9/30/2027 | 14,900 | 284 | 281 | 603 | 6 |
9/30/2026 | 14,452 | 270 | 204 | 538 | 8 |
9/30/2025 | 14,248 | 143 | 200 | 500 | 9 |
9/30/2024 | 14,688 | 18 | 277 | 543 | N/A |
6/30/2024 | 14,855 | 74 | 305 | 574 | N/A |
3/31/2024 | 15,194 | 158 | 360 | 619 | N/A |
12/31/2023 | 15,356 | 213 | 418 | 664 | N/A |
9/30/2023 | 15,395 | 205 | 415 | 667 | N/A |
6/30/2023 | 15,316 | 115 | 375 | 609 | N/A |
3/31/2023 | 14,746 | 12 | 202 | 429 | N/A |
12/31/2022 | 14,340 | -54 | 104 | 332 | N/A |
9/30/2022 | 14,121 | -120 | 47 | 274 | N/A |
6/30/2022 | 13,242 | 795 | -308 | -64 | N/A |
3/31/2022 | 12,999 | 754 | -116 | 135 | N/A |
12/31/2021 | 13,312 | 904 | -234 | 15 | N/A |
9/30/2021 | 13,680 | 1,108 | N/A | 260 | N/A |
6/30/2021 | 14,506 | 112 | 626 | 880 | N/A |
3/31/2021 | 12,890 | -142 | -64 | 203 | N/A |
12/31/2020 | 12,582 | -230 | -68 | 238 | N/A |
9/30/2020 | 12,670 | -547 | -80 | 246 | N/A |
6/30/2020 | 12,994 | -515 | -646 | -270 | N/A |
3/31/2020 | 15,587 | -511 | 50 | 451 | N/A |
12/31/2019 | 16,304 | -641 | 260 | 675 | N/A |
9/30/2019 | 16,526 | -491 | -160 | 308 | N/A |
6/30/2019 | 16,750 | -1,842 | 263 | 745 | N/A |
3/31/2019 | 17,025 | -1,467 | 347 | 869 | N/A |
12/31/2018 | 17,393 | -1,486 | 141 | 678 | N/A |
9/30/2018 | 17,439 | -1,685 | 143 | 679 | N/A |
6/30/2018 | 17,273 | 14 | N/A | 686 | N/A |
3/31/2018 | 16,786 | 161 | N/A | 453 | N/A |
12/31/2017 | 16,391 | 519 | N/A | 632 | N/A |
9/30/2017 | 16,213 | 877 | N/A | 746 | N/A |
6/30/2017 | 16,131 | -357 | N/A | -1,178 | N/A |
3/31/2017 | 16,486 | -572 | N/A | -1,185 | N/A |
12/31/2016 | 16,583 | -1,541 | N/A | -1,137 | N/A |
9/30/2016 | 16,790 | -1,546 | N/A | -1,034 | N/A |
6/30/2016 | 17,055 | -772 | N/A | 658 | N/A |
3/31/2016 | 18,095 | -550 | N/A | 905 | N/A |
12/31/2015 | 19,031 | 430 | N/A | 612 | N/A |
9/30/2015 | 20,023 | 460 | N/A | 397 | N/A |
9/30/2014 | 22,041 | 307 | N/A | 797 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (42.9% al año) de ADNT es superior a la tasa de ahorro (2.6%).
Beneficios vs. Mercado: Se prevé que los beneficios (42.9% al año) de ADNT crezcan más rápidamente que el mercado US (15.3% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de ADNT crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (1.2% al año) de ADNT crezcan más despacio que el mercado de US (8.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 1.2% al año) de ADNT crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de ADNT sea baja dentro de 3 años (10%).